Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma.
Overview & Synopsis
Open access biomedical research article published in Front Immunol.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Early dynamics of eosinophils and the neutrophil-to-lymphocyte ratio are associated with severe immune-related adverse events during nivolumab therapy for metastatic renal cell carcinoma. |
|---|---|
| Author / Organization | Fiala O, Králíček J, Kopecký J, Vočka M, Buchler T, Študentová H, Obertová J, Rondzíková B, Matějů M, Šafčák D, Hrnčár M, Priester P, Spisarová M, Zemánková A, Lohynská R, Tkadlecová M, Grmelová L, Stránský P Jr, Melichar B, Palacka P, Poprach A |
| Subject & Discipline | Front Immunol |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-120649 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |